20:13 IST
BSE
Annual General Meeting
Aptus Pharma Annual General Meeting
Aptus Pharma Ltd issued a corrigendum to its 16th AGM notice regarding inadvertent errors in the explanatory statement for item no. 3.
Aptus Pharma Ltd
- Share price
- ₹385.20
- Market cap
- ₹660.6 Cr
- Revenue (annual)
- ₹46.57 Cr
- Net profit (annual)
- ₹4.62 Cr
- P/E (TTM)
- 143.0×Sector 47.4×
- Promoter holding
- 72.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 2Annual General Meeting 2Other Announcement 1Fund Raise 1Board Meeting Outcome 1Board Meeting Date 1Annual Report 1
Time
9 announcements with these filters
13:34 IST
BSE
Fund Raise
Aptus Pharma Fund Raise of ₹44.88 Cr
Aptus Pharma Limited's Board has approved raising ₹44.88 Crore through a preferential equity issue. Funds will support manufacturing capacity expansion, working capital, and Pan-India growth initiatives.
- Value
- ₹44.88 Cr
- Execution
- 36 months
19:36 IST
BSE
Annual Report
Aptus Pharma Annual Report
Aptus Pharma has filed its Annual Report for FY 2025-26 with the exchange. The report includes the notice for the upcoming 16th Annual General Meeting.
19:26 IST
BSE
Annual General Meeting
Aptus Pharma Annual General Meeting
Aptus Pharma Limited issued a notice for its 16th AGM on September 14, 2026, which includes a proposal for a preferential allotment of equity shares.
- Value
- ₹44.88 Cr
18:06 IST
BSE
Capital Structure Change
Aptus Pharma Capital Structure Change
Aptus Pharma approved a preferential issue of 16,02,870 equity shares at Rs. 280 per share, raising approximately Rs. 44.88 Crore. The board also scheduled the 16th AGM.
- Value
- ₹44.88 Cr
14:39 IST
BSE
Board Meeting Outcome
Aptus Pharma Board Meeting Outcome
Aptus Pharma Limited issued a clarification regarding typographical errors in its August 8, 2026, board meeting outcome. The correction specifies the meeting venue and annexure titles.
17:27 IST
BSE
Capital Structure Change
Aptus Pharma Capital Structure Change
Aptus Pharma approved a preferential issue of 16,10,100 equity shares to various allottees. The company also fixed the Annual General Meeting date for September 14, 2026.
18:42 IST
BSE
Board Meeting Date
Aptus Pharma Board Meeting Date
Aptus Pharma Ltd will hold a board meeting on August 8, 2026, to consider a proposal for raising funds through preferential allotment of equity securities.
13:16 IST
BSE
Other Announcement
Aptus Pharma Other Announcement
Aptus Pharma Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulatory requirements.